New findings reveal RG6501 cell therapy shows promising long-term visual improvements for geographic atrophy patients ...

Confluent stock has had a difficult time since late 2021, partly thanks to the business's declining growth rates. Confluent's earnings growth is expected to accelerate, and that could be rewarded ...

Methods This retrospective study included only eyes with non-neovascular AMD and associated SRF. Eyes with evidence of MNV were excluded. Spectral-domain optical coherence tomography (SD-OCT) was ...

Confluent's announcement represents a significant step in its strategy to position data streaming as the foundation for enterprise AI development. By unifying batch and streaming processing, the ...

Confluent’s Q1 earnings showed robust topline growth and improving profitability metrics. Despite uncertainty in larger customer spending, Confluent’s rapidly growing customer base could set ...

For the quarter ended December 31, 2024, its subscription revenue grew 24% to $251 million. Confluent Cloud revenue grew 38% to $138 million, and non-GAAP operating margin was 5%.

Confluent (CFLT 2.00%) stock is seeing a big valuation pullback Friday. The company's share price was down 7.9% as of 2:30 p.m. ET, and had been down as much as 11% earlier in trading.

There is evidence for a genetic component that contributes to this dysfunction; the presence of systemic disorders, like diabetes and obesity, and ocular conditions, like soft confluent drusen and ...

Shares of data infrastructure software company, Confluent (NASDAQ:CFLT) jumped 22.6% in the afternoon session after the company delivered strong fourth-quarter results, with revenue and operating ...

Confluent also showed strong momentum in terms of growing its customer base, saying that the number of clients generating at least $100,000 in annual sales rose 12% from a year ago, to 1,381.

Investment Thesis Confluent, Inc. (NASDAQ: CFLT) has been a tough stock to hold, with booms and busts this past year. Most of CFLT's truly die-hard shareholders who got out would have sold at a loss.

Confluent, Inc. (NASDAQ: CFLT), the data streaming pioneer, today announced financial results for its third quarter of 2024, ended September 30, 2024.